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Interactions Drive Neoplastic
Transformation in DrosophilaStromal cells play a supportive role in the initiation and progression of
carcinomas. A new study in Drosophila implicates mesenchymal cells in
supporting EGF receptor-driven tumor growth and cellular transformation of
epithelial tissues.Marco Mila´n
Carcinomas, malignant neoplasms of
epithelial origin, are the most common
form of human cancer. Mesenchymal
cells in the stroma regulate the
expression and remodeling of the
extracellular matrix (ECM) and produce
growth factors that support the
survival and proliferation of epithelial
transformed cells. As they reported
recently in Current Biology, Herranz
et al. [1] have used the genetic model
species Drosophila to dissect the
underlying molecular and cellular
mechanisms driving tumor–stroma
interactions. This work underscores
the contribution of resident
mesenchymal cells in promoting
the neoplastic transformation of
EGF-receptor-expressing epithelial
cells and identifies Dpp and Wingless
as the signaling molecules driving
growth of these two cell populations.
EGF-receptor gene amplification
has been reported in a wide range of
carcinomas,andmutations that activate
the small G protein Ras are found
in 20–25% of all human tumors.
However, neither EGF-receptor
overexpression nor the presence of
activated Ras is sufficient to drive
malignant transformation, andadditional oncogenic mutations are
required for disease progression. In
this regard, the imaginal primordia of
Drosophila—monolayered epithelia
within the feeding larvae that grow
one-thousand fold in cell number and
tissue size—have been used to identify
newmolecular elements that cooperate
with these two oncogenes in driving
tumor growth, epithelial transformation,
basement membrane degradation,
and invasive behavior [2–5]. Mutations
that affect the Scribbled–Disc
Large–Lgl cell polarity complex or
those causing mitochondrial
dysfunction, or overexpression of
certain miRNAs, cooperate with
EGF receptor/Ras dysregulation in
promoting tumorigenesis. In all these
cases, tumorigenesis relies on a
JNK-dependent transcriptional
program that regulates the invasion of
transformedcells, drives theexpression
of the mitogenic molecules responsible
for tumor growth, and induces the
expression of matrix metalloproteins
(MMPs) involved in basement
membrane degradation, a prerequisite
for tissue invasiveness [6,7].
The work of Herranz et al. [1] stems
from the observation that depletion
of the Polycomb group epigenetic
silencer Pipsqueak, a BTB-containingnuclear protein [8], cooperates with
EGF receptor to elicit malignant
neoplastic growth of imaginal
primordia. The multilayered tumor
induces the expression of MMP1 and
the consequent degradation of the
basement membrane and becomes
highly metastatic, as transformed cells
are found in distant internal organs
such as the gut andmalphigian tubules.
Remarkably, Pipsqueak behaves as a
tumor-promoting gene in a Drosophila
Notch-driven epithelial tumor model
[9]. This observation thus reinforces the
context-dependent tumor suppressor
or tumor-promoting roles of many
cancer genes.
As is often the case, the initial
observation made by Herranz et al.
[1] that allowed the identification
of a mesenchymal cell population
supporting EGF-receptor-driven tumor
growth was unexpected, but a key
finding. During the characterization of
the oncogenic cooperation between
EGF receptor and Pipsqueak,
GFP-positive EGF-receptor-expressing
cells were found to intermingle
with ‘‘groups of cells not expressing
GFP’’ (Figure 1). Further functional
characterization of this population
indicated that the GFP-negative cells
are resident myoblasts that proliferate
in response to Dpp — a member of the
TGF-b superfamily — produced by the
tumor. Thus, those myoblasts abutting
the transformedcell population showed
strong activation of the Dpp pathway
and elevated mitotic activity.
Genetically elegant experiments
performed by Herranz et al. [1]
demonstrated that the proliferative
myoblast population plays a major role
in driving neoplastic tumor growth.
Thus,selectiveablationof themyoblasts
Figure 1. Tumor–stroma interactions in Drosophila epithelial tumors.
A sketch depicting the spatial organization of epithelial (green) and mesenchymal (red) cells
during normal development and in a neoplastic tumor. EGF receptor-expressing (green nuclei)
transformed epithelial cells induce the expression of the mitogenic molecules Wingless and Dpp,
which drive proliferation of epithelial and mesenchymal cells, respectively. The expression of
Perlecan by the transformed cells is thought to potentiate Dpp signaling in mesenchymal cells.
These cells support tumor growth and are required for epithelial transformation.
Dispatch
R659by the expression of the pro-apoptotic
gene reaper, depletion of the Dpp
signaling molecule in the transformed
cell population, or blockade of the Dpp
signaling transduction pathway in the
myoblast cell population completely
rescued all aspects of the oncogenic
cooperation between EGF receptor
and Pipsqueak depletion.
Transformed cells promote the
proliferation of the accompanying
myoblast cell population not only
by expressing Dpp but also by
potentiating Dpp signaling in the target
tissue. Perlecan, a secreted heparan
sulfate proteoglycan (HSPG) that acts
as a potent cofactor of several secreted
growth factors [10], was shown to be
highly expressed by the transformed
cells and preferentially found in the
myoblasts. Overexpression of Perlecan
in tumor cells appears to be crucial in
the oncogenic cooperation between
these two cell populations, as
depletion of Perlecan completely
rescued tumor growth while its
co-expression with EGF receptor drove
neoplastic growth and induced high
levels of Dpp activation in nearby
proliferating myoblasts. The signaling
molecule Wingless, a target of JNK
in transformed epithelial cells [11],
was also shown to contribute to
EGF-receptor-driven tumorigenesis.
However, in this case, Wingless played
an autocrine role, as the inhibition
of this signaling pathway in EGF-
receptor-expressing cells was
sufficient to rescue tumor growth.
The paracrine role of Dpp in
mediating tumor–stroma interactions
in fly epithelial tumors resembles therole of TGF-b in mediating interactions
between colorectal cancer cells and
stromal cells in distant metastatic sites
[12]. In both cases, transformed cells
express but do not respond to the
ligand, and Dpp/TGF-b signaling in
stromal cells is required to support
tumor initiation and progression. While
the TGF-b-regulated ligand interleukin
1 is known to signal back from the
stroma to support the growth and
survival of metastatic colorectal cancer
cells [12], the identity of the signal in the
fly tumor model remains unidentified
[1]. The new study [1] provides an
ideal genetic model system for the
future identification of the signal. An
unexpected feature of this signal is
that it appears to be sufficient to
drive neoplastic transformation
and the invasive behavior of EGF
receptor-expressing epithelial cells.
The long-recognized relationship
between the immune system and
cancer has also been fruitfully
addressed in this Drosophila epithelial
tumor model. Circulating blood
cells (hemocytes) are attracted by
MMP-mediated disruption of the
basement membrance, proliferate in
response to the cytokines expressed
by transformed epithelial cells, and
restrict tumor growth by inducing
TNF-mediated apoptosis of tumor cells
[13,14]. Similarly to fibroblasts in
human cancers, hemocytes also
express the components of the ECM
and contribute to the repair of the
basement membrane during wound
healing and tumorigenesis. Thus, solid
epithelial tumors in Drosophila appear
to be functionally and structurallyorganized as organs, as they consist
of transformed and stromal cells
that interact to promote growth and
to shape the tumor. These results
highlight that the differences between
invertebrate and mammalian tumors
are, in fact, fewer than what was
originally believed.
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